References
- Cheung WMW, Hui WS, Chu PWK, Chiu SW, Ip NY. 2000. Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells. FEBS Lett. 486(3):291–296.
- Hasnat MA, Pervin M, Cha KM, Kim SK, Lim BO. 2015. Anti-inflammatory activity on mice of extract of Ganoderma lucidum grown on rice via modulation of MAPK and NF-κB pathways. Phytochemistry. 114:125–136.
- Huang SZ, Cheng BH, Ma QY, Wang Q, Kong FD, Dai HF, Qiu SQ, Zheng PY, Liu ZQ, Zhao YX. 2016. Anti-allergic prenylated hydroquinones and alkaloids from the fruiting body of Ganoderma calidophilum. RSC Adv. 6(25):21139.
- Isaka M, Chinthanom P, Mayteeworakoon S, Laoteng K, Choowong W, Choeyklin R. 2018. Lanostane triterpenoids from cultivated fruiting bodies of the basidiomycete Ganoderma australe. Nat Prod Res. 32(9):1044–1049.
- Li CG, Luo Q, Guo PX, Chen LL, Cheng YX. 2016. Petchiethers A and B, novel meroterpenoids with a 14- or 15-membered ring from Ganoderma petchii. Phytochem Lett. 18:14–18.
- Liao GF, Wu ZH, Liu Y, Yan YM, Lu RM, Cheng YX. 2019. Ganocapenoids A–D: four new aromatic meroterpenoids from Ganoderma capense. Bioorg Med Chem Lett. 29(2):143–147.
- Lu QY, Jin YS, Zhang QF, Zhang ZF, Heber D, Go VLW, Li FP, Rao JY. 2004. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett. 216(1):9–20.
- Lu SY, Peng XR, Dong JR, Yan H, Kong QH, Shi QQ, Li DS, Zhou L, Li ZR, Qiu MH. 2019. Aromatic constituents from Ganoderma lucidum and their neuroprotective and anti-inflammatory activities. Fitoterapia. 134:58–64.
- Luo Q, Cao WW, Wu ZH, Wang SM, Cheng YX. 2019. Zizhines G-O, AchE inhibitory meroterpenoids from Ganoderma sinensis. Fitoterapia. 134:411–416.
- Luo Q, Di L, Dai WF, Lu Q, Yan YM, Yang ZL, Li RT, Cheng YX. 2015. Applanatumin A, a new dimeric meroterpenoid from Ganoderma applanatum that displays potent antifibrotic activity. Org Lett. 17(5):1110–1113.
- Luo Q, Yang XH, Yang ZL, Tu ZC, Cheng YX. 2016. Miscellaneous meroterpenoids from Ganoderma applanatum. Tetrahedron. 72(30):4564–4574.
- Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL. 2013. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol. 698(1-3):6–18.
- Seto SW, Lam TY, Tam HL, Au ALS, Chan SW, Wu JH, Yu PHF, Leung GPH, Ngai SM, Yeung JHK, et al. 2009. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine. 16(5):426–436.
- Tian L, Wang XL, Wang YZ, Cheng YX. 2015. Two new alkaloids from Ganoderma cochlear. Nat Prod Res Dev. 27:1325–1328.
- Wang XL, Dou M, Luo Q, Cheng LZ, Yan YM, Li RT, Cheng YX. 2017. Racemic alkaloids from the fungus Ganoderma cochlear. Fitoterapia. 116:93–98.
- Wang XL, Zhou FJ, Dou M, Yan YM, Wang SM, Di L, Cheng YX. 2016. Cochlearoids F–K: phenolic meroterpenoids from the fungus Ganoderma cochlear and their renoprotective activity. Bioorg Med Chem Lett. 26(22):5507–5512.
- Yan YM, Ai J, Zhou LL, Arthur CKC, Li R, Nie J, Fang P, Wang XL, Luo J, Hu Q, Hou FF, et al. 2013. Lingzhiols, unprecedented rotary door-shaped meroterpenoids as potent and selective inhibitors of p-Smad3 from Ganoderma lucidum. Org Lett. 15(21):5488–5491.
- Yan YM, Wang XL, Luo Q, Jiang LP, Yang CP, Hou B, Zuo ZL, Chen YB, Cheng YX. 2015. Metabolites from the mushroom Ganoderma lingzhi as stimulators of neural stem cell proliferation. Phytochemistry. 114:155–162.
- Zhang JJ, Dong Y, Qin FY, Cheng YX. 2019. Australeols A-F, neuroprotective meroterpenoids from Ganoderma australe. Fitoterapia. 134:250–255.
- Zhou FJ, Nian Y, Yan YM, Gong Y, Luo Q, Zhang Y, Hou B, Zuo ZL, Wang SM, Jiang HH, et al. 2015. Two new classes of T-type calcium channel inhibitors with new chemical scaffolds from Ganoderma cochlear. Org Lett. 17(12):3082–3085.